eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
6/2011
vol. 15
 
Share:
Share:
abstract:
Review paper

Langerhans cell histiocytosis – the role of radiation therapy

Ewa Ziółkowska
,
Tomasz Wiśniewski
,
Katarzyna Indrak-Rawicka
,
Wiesława Windorbska

Wspolczesna Onkol 2011; 15 (6): 350–353
Online publish date: 2011/12/28
View full text Get citation
 
PlumX metrics:
Langerhans cell histiocytosis is a rare illness and its ethiology is unknown. About 1200 new morbidity is registered in the USA annually. Langerhans cell histiocytosis has a wide range of signs and differential prognosis. Bones are the most common localization of disease (40-78%). Nowadays histiocytosis hasn’t got clinical trials and standard of treatment. Surgery is the treatment of choice in limited form of histiocytosis, but in diffuse form the chemotherapy is always used. The role of radiation therapy in histiocytosis is unknown. The most of researchers recommends the radiotherapy in following conditions: reccurence or progresion of disease, spinal cord compression, bone pain or bone’s break threat, exophthalmus, non-surgical local changes. The aim of this study is the review of literature about using radiation therapy in treatment of Langerhans cell histiocytosis.
keywords:

Langerhans cell histiocytosis, treatment, radiotherapy

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.